BioCentury
ARTICLE | Company News

Lupin management update

February 24, 2014 8:00 AM UTC

Lupin Ltd. (NSE:LUPIN; BSE:500257), Mumbai, India Business: Pharmaceuticals, Cardiovascular, Endocrine/Metabolic Hired: Maurice Chagnaud as president of Europe and head of inhalation strategy, formerl...